J9039 Injection, blinatumomab
J-Codes
Also known as: blinatumomab, Blincyto
Intravenous injection of blinatumomab, a bispecific T-cell engager monoclonal antibody that targets CD19 and CD3.
Clinical Context
Used to treat relapsed or refractory B-cell acute lymphoblastic leukemia by engaging cytotoxic T-cells to attack CD19-positive B-cells.
RVU Breakdown
| Work RVU | 0.00 |
| Practice Expense RVU | 0.00 |
| Malpractice RVU | 0.00 |
| Total RVU | 0.00 |
Specialties
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.